Full text is available at the source.
Abstract
Individuals with metabolic syndrome are at an increased risk of developing chronic kidney disease.
- Metabolic syndrome is linked to both chronic kidney disease and the progression of existing kidney conditions.
- There is a higher likelihood of developing diabetes among individuals with metabolic syndrome, which may lead to diabetic kidney disease.
- Current treatments for diabetic kidney disease include several classes of medications that offer significant protection for the kidneys.
- Despite existing treatments, diabetic kidney disease continues to persist and progress, indicating a need for new therapeutic approaches.
- Emerging targets from preclinical models suggest potential pathways for developing novel treatments aimed at kidney protection.
Simplified